SCHEMBL5586829

SCHEMBL5586829

CCCCCCCCOOc1c(C)c(C)c(C)c(C(=O)O)c1O

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 2/20 0.39
PLA2G5 P39877 1/20 0.39
ESR1 P03372 3/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37
PLA2G4B P0C869 1/20 0.36
AKR1C4 P17516 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
AKR1C1 Q04828 1/20 0.35
BID P55957 2/20 0.35
BCL2L1 Q07817 2/20 0.35
MCL1 Q07820 2/20 0.35
BAK1 Q16611 2/20 0.35
RARB P10826 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5588648 1.00 PLA2G2A (0.39) PLA2G2APLA2G5ESR1MEN1KMT2A
SCHEMBL5589254 1.00 PLA2G2A (0.39) PLA2G2APLA2G5ESR1MEN1KMT2A
SCHEMBL5587628 1.00 PLA2G2A (0.39) PLA2G2APLA2G5ESR1MEN1KMT2A
SCHEMBL5588640 1.00 PLA2G2A (0.39) PLA2G2APLA2G5ESR1MEN1KMT2A
SCHEMBL5587843 0.99 PLA2G2A (0.36) PLA2G2APLA2G5ESR1MEN1KMT2A
SCHEMBL5589191 0.94 ESR1 (0.36) PLA2G2APLA2G5ESR1TP53TSHR
SCHEMBL5588385 0.91 MEN1 (0.41) PLA2G2AESR1MEN1KMT2ATDP1
SCHEMBL5588296 0.91 MEN1 (0.41) PLA2G2AESR1MEN1KMT2ATDP1
SCHEMBL5588316 0.91 MEN1 (0.41) PLA2G2AESR1MEN1KMT2ATDP1
SCHEMBL5590236 0.88 LDHA (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 PLA2G2A 4233/4885PLA2G5 4231/4885ESR1 1108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.